Tealwood Asset Management Inc Horizon Therapeutics Public LTD CO Transaction History

Tealwood Asset Management Inc

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 17, 2023	SELL	$62.39 - $113.8 $83,165 - $151,695	-1,333 Reduced 8.76%	13,890 $1.58 Million
Q3 2022 Nov 16, 2022	BUY	$58.92 - $84.67 $5,302 - $7,620	90 Added 0.59%	15,223 $942,000
Q2 2022 Jul 20, 2022	SELL	$79.4 - $116.36 $29,378 - $43,053	-370 Reduced 2.39%	15,133 $1.21 Million
Q1 2022 May 02, 2022	SELL	$86.42 - $109.81 $20,827 - $26,464	-241 Reduced 1.53%	15,503 $1.63 Million
Q4 2021 Mar 15, 2022	SELL	$98.56 - $119.91 $46,126 - $56,117	-468 Reduced 2.89%	15,744 $1.7 Million

Q3 2021 Dec 02, 2021	SELL	$91.91 - $110.37 $176,099 - $211,468	-1,916 Reduced 10.57%	16,212 $1.78 Million
Q1 2021 Jun 21, 2021	SELL	$71.83 - $95.48 $5,315 - $7,065	-74 Reduced 0.41%	18,128 $1.67 Million
Q4 2020 Mar 09, 2021	SELL	$67.0 - $84.39 $88,105 - $110,972	-1,315 Reduced 6.74%	18,202 $1.33 Million
Q3 2020 Dec 14, 2020	SELL	$55.23 - $79.93 $10,769 - $15,586	-195 Reduced 0.99%	19,517 $1.52 Million
Q2 2020 Aug 03, 2020	BUY	$30.2 - $56.98 $595,302 - $1.12 Million	19,712 New	19,712 $1.1 Million

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Tealwood Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Tealwood Asset Management Inc with notifications on news.